IP Library Granted Patent US 8,568,767
Granted Patent B2
US 8,568,767 · App. 13/737,066 · Granted Oct 29, 2013

Dietary fiber composition

Inventors: Nils William Ahlgren (Redwood City, CA); Ronald Lee Dahl (Lincoln, NE); Monte Lee Friesen (Lincoln, NE); Alexander Mark Schobel (Whitehouse Station, NJ)
Assignee: Novartis AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,767
App. No.
13/737,066
Granted
Oct 29, 2013
Kind
B2
Abstract

The present invention provides a chewable composition containing granules of water-soluble dietary fiber. The chewable composition has highly agreeable organolpetic properties and is consumable without the need of an ingestion aid.

Claims (14)

1. A chewable fiber composition comprising compressed granules, wherein said granules comprise a water-soluble dietary fiber and said fiber comprises fructooligosaccharide, arabinogalactan or mixtures thereof, and said granules have a size distribution of less than 10% by weight of granules having particle size larger than about 850 μm and less than 35% by weight of granules having particle size smaller than about 75 μm.

2. The chewable fiber composition of claim 1 , wherein said granules have a size distribution of less than 4% by weight of granules having particle size larger than about 850 μm and less than 20% by weight of granules having particle size smaller than about 75 μm.

3. The chewable fiber composition of claim 1 , wherein said water-soluble fiber comprises fructooligosaccharide having an average degree of polymerization of less than 8 monomeric fructose units.

4. The chewable fiber composition of claim 1 , wherein said composition further comprises maltodextrin and sorbitol.

5. A chewable fiber composition comprising agglomerated granules, said granules comprising a water-soluble fiber and at least 50 wt % of said water-soluble fiber is fructooligosaccharide, arabinogalactan or mixtures thereof, wherein the fructooligosaccharide has an average degree of polymerization of less than 8 monomeric fructose units.

6. The chewable fiber composition of claim 5 , wherein said composition further comprises maltodextrin and sorbitol.

7. A chewable tablet comprising agglomerated granules, wherein said granules comprise a water-soluble fiber of fructooligosaccharide, arabinogalactan or mixtures thereof, wherein the fructooligosaccharide has an average degree of polymerization of less than 8 monomeric fructose units, said tablet having a hardness between 10 kp and 20 kp.

8. The chewable tablet according to claim 7 additionally comprising maltodextrin and sorbitol.

9. The chewable composition according to claim 7 wherein said water-soluble fiber consists essentially of agglomerated granules consisting essentially of fructooligosaccharide having an average degree of polymerization of less than 8 monomeric fructose units.

10. A chewable fiber composition comprising compressed granules wherein said granules comprise a water-soluble dietary fiber and said fiber comprises fructooligosaccharide, arabinogalactan or mixtures thereof, the fructooligosaccharide having a degree of polymerization at less than 8 monomeric fructose units, and said granules have a size of distribution of less than 10% by weight of granules having particle size larger than about 850 μm and less than 35% by weight of granules having particle size smaller than about 75 μm.

11. The composition of claim 10 , wherein the composition comprises 40 to 60 wt % of the water-soluble fiber.

12. The composition of claim 1 , wherein the composition comprises 40 to 60 wt % of the water-soluble fiber.

13. The composition of claim 5 , wherein the composition comprises 40 to 60 wt % of the water-soluble fiber.

14. The tablet of claim 7 , wherein the tablet comprises 40 to 60 wt % of the water-soluble fiber.

Assignments (3)
CHANGE OF NAME Recorded Mar 5, 2024
From: GSK CONSUMER HEALTHCARE SARL
To: HALEON CH SARL
Reel/Frame 066650/0581 →
CHANGE OF NAME Recorded Mar 1, 2024
From: GSK CONSUMER HEALTHCARE S.A.
To: GSK CONSUMER HEALTHCARE SARL
Reel/Frame 066621/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2020
From: NOVARTIS AG
To: GSK CONSUMER HEALTHCARE S.A.
Reel/Frame 051658/0343 →
Continuity (4)
Continuation 13231173 · Sep 13, 2011
Continuation 11057480 · Feb 14, 2005
Provisional Application 60546298 · Feb 20, 2004
Related Publication 20130122171A1 · May 16, 2013